Abstract
Behavior controlled by various schedules of reinforcement is useful for characterizing drugs as well as for analyzing the mechanisms of action of their effects on behavior. Conditioned avoidance techniques have been useful for studying neuroleptics and for predicting their clinical antipsychotic activity; the possible involvement of dopaminergic mechanisms in the effects of neuroleptics on avoidance behavior is discussed. Tricyclic antidepressant agents have been studied in assays involving interactions with other agents, such as cocaine, amphetamine and tetrabenazine. One type of operant behavior, Sidman avoidance, has been used as a particularly sensitive assay for such drug interactions. Another schedule, in which “observing” responses in pigeons are measured, seems to provide a method for studying antidepressants without involving drug interaction phenomena. For tricyclic compounds, facilitation of observing responses and weak potency of conditioned avoidance inhibition constitute a pharmacological profile that seems to have some predictive value for clinical imipramine-like antidepressant activity. “Conflict” (punishment) schedules have been useful for predicting antianxiety activity in man. Although the degree of anticonflict effect observed is consistent with Dews’ rate dependency hypothesis, this principle does not fully account for the observed drug effects. In the conflict model, the actions of benzodiazepines differ in drug-naive versus drug-experienced animals. Experiments with parachlorophenylalanine have not yet provided clear support for the postulated role of serotonin in related phenomena.— Cook, L., And J. Sepinwall. Reinforcement schedules and extrapolations to humans from animals in behavioral pharmacology. Federation Proc. 34: 1889–1897, 1975.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Abbreviations
- VI:
-
variable interval
- FR:
-
fixed ratio
- CER:
-
conditioned emotional response
- PCPA:
-
parachlorophenylalanine
References
Bartholini, G., W. Haefely, M. Jalfre, H. H. Keller and A. Pletscher. Br. J. Pharmacol. 46: 736, 1972.
Blakely. T. A., and L. F. Parker. Pharmacol. Biochem. Behav. 1: 609, 1973.
Buser, P., L. Cook, C. Giurgea, E. Jacobsen, O. S. Ray, M. Richelle, A. P. Silverman, L. Stein and Z. Votava. In: The Neuroleptics. Mod. Probl. Pharmacopsychiatry, Vol. 5, edited by D. P. Bobon, P. A. J. Janssen and J. Bobon. Basel: Karger, 1970, p. 85–108.
Cannizzaro, G., S. Nigito, P. M. Provenzano and T. Vitikova. Psychopharmacologia 26: 173, 1972.
Carlsson, A., and M. Lindqvist. Acta Pharmacol. Toxicol. 20: 140, 1963.
Cook, L., and A. C. Catania. Federation Proc. 23: 818, 1964.
Cook, L., and A. B. Davidson. In: The Benzodiazepines, edited by S. Garattini, E. Mussini and L. O. Randall. New York: Raven, 1973, p. 327–345.
Cook, L., and R. T. Kelleher. In: Neuro-Psychopharmacology, Vol. 2, edited by E. Rothlin. Amsterdam: Elsevier, 1961, p. 77–92.
Cook, L., and R. T. Kelleher. Ann. N. Y. Acad. Sci. 96: 315, 1962.
Cook, L., and J. Sepinwall. IN: Emotions-Their Parameters and Measurement, edited by L. Levi. New York: Raven, 1975.
Cook, L., and E. Weidley. Ann. N. Y. Acad. Sci. 66: 740, 1957.
Corrodi, H., K. Fuxe and T. Hokfelt. Life Sci. 6: 767, 1967.
Crow, T. J., and C. Gillbe. Nature New Biol. 245: 27, 1973.
Davidson, A. B., and L. Cook. Psychopharmacologia 15: 159, 1969.
Davies, J. A., B. Jackson and P. H. Redfern. Neuropharmacology 12: 735, 1973.
Demaio, D. Arzneim.-Forsch. 22: 919, 1972.
Dews, P. B. Naunyn-Schmiedebergs Arch. Exp. Pathol. Pharmakol. 248: 296, 1964.
Foree, D. D., F. H. Moretz and D. E. Mcmillan. J. Exp. Anal. Behav. 20: 291, 1973.
Geller, I., and K. Blum. Eur. J. Pharmacol. 9: 319, 1970.
Geller, I., and J. Seifter. Psychopharmacologia 1: 482, 1960.
Goodman, L. S., and A. Oilman. The Pharmacological Basis of Therapeutics, 4th ed. New York: Macmillan, 1970, p. 155–165.
Gross, H., and E. Langner. Int. Pharmacopsychiatry 4: 220, 1970.
Hanson. H. M., J. J. Witoslawski and E. H. Campbell. J. Exp. Anal. Behav. 10: 565, 1967.
Hanson, H. M., C. A. Stone and J. J. Witoslawski. J. Pharmacol. Exp. Ther. 173: 117, 1970.
Ionesco, R., S. U. Nica, L. Oproiu, A. Niturad and B. Tudorache. Pharmakopsychiatr. Neuro-Psychopharmakol. 6: 294, 1973.
Jalfre, M., M. A. Monachon and W. Haefely. In: Proc. First Canadian International Symposium on Sleep, edited by D. J. McClure. Montreal: Hoffmann-La Roche, 1972.
Janssen, P. A. J., C. J. E. Nlemegeers and K. H. L. Schellekens. Arzneim.-Forsch. 15: 104, 1965.
Jequier, E., W. Lovenberg and A. Sjoerdsma. Mol. Pharmacol. 3: 247, 1967.
Kelleher, R. T., W. C. Riddle and L. Cook. J. Exp. Anal. Behav. 5: 3, 1962.
Kelleher, R. T., and W. H. Morse. Ergeb. Physiol. Biol. Chem. Exp. Pharmakol. 60: 1, 1968.
Koe, B. K., and A. Weissman. J. Pharmacol. Exp. Ther. 154: 499, 1966.
Lichtenstein (Stitzer), M. Paper presented at 45th Annual Meeting, Eastern Psychological Association, Philadelphia, Pa., April 18–20, 1974.
Margules, D. L., and L. Stein. In: Neuro-psychopharmacology, edited by H. Brill. Amsterdam: Excerpta Medica Foundation, 1967, p. 108–120.
Margules, D. L., and L. Stein. Psychopharmacologia 13: 74, 1968.
Matthysse, S. Federation Proc. 32: 200, 1973.
Mcmillan, D. E. J. Exp. Anal. Behav. 19: 133, 1973.
Millenson, J. R., and J. Leslie. Neuropharmacology 13: 1, 1974.
Morpurgo, C., and W. Theobald. Psychopharmacologia 6: 178, 1964.
Nlemegeers, C. J. E., F. J. Verbruggen and P. A. J. Janssen. Psychopharmacologia 16: 161, 1969.
Nlemegeers, C. J. E., F. J. Verbruggen and P. A. Janssen. Psychopharmacologia 16: 175, 1969.
Pletscher, A., and M. Daprada. In: Neuro-Psychopharmacology, edited by H. Brill. Amsterdam: Excerpta Medica Foundation, 1967, p. 304–311.
Robichaud, R. C., and K. L. Sledge. Life Sci. 8: 965, 1969.
Ruiz, M., and J. M. Monti. Eur. J. Pharmacol. 20: 93, 1972.
Scheckel, C. L., and E. Boff. Psychopharmacologia 5: 198, 1964.
Sepinwall, J., F. S. Grodsky, J. W. Sullivan and L. Cook. Psychopharmacologia 31: 375, 1973.
Sldman, M. Science 118: 157, 1953.
Snyder, S. H., S. P. Banerjee, H. I. Yamamura and D. Greenberg. Science 184: 1243, 1974.
Stille, G., H. Lauener and E. Elchenberger Farmaco, Ed. Prat. 26: 603, 1971.
Thompson, D. M., and P. B. Corr. J. Exp. Anal. Behav. 21: 151, 1974.
Ueki, S., N. Ogawa, S. Watanabe, Y. Gomita, Y. Araki, M. Fujiwara, C. Kamei, K. Shimomura, M. Inoue, R. Ohishi, N. Ibii and K. Tanaka. Nippon Yakurigaku Zasshi. 69: 85, 1973.
Van Rossum, J. M. In: Neuro-Psychopharmacology, edited by H. Brill. Amsterdam: Excerpta Medica Foundation, 1967, p. 321–329.
Wise, C. D., B. D. Berger and L. Stein. Science 177: 180, 1972.
Wise, C. D., B. D. Berger and L. Stein. Biol. Psychiatry 6: 3, 1973.
Wuttke, W., and R. T. Kelleher. J. Pharmacol. Exp. Ther. 172: 397, 1970.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1975 Springer Science+Business Media New York
About this chapter
Cite this chapter
Cook, L., Sepinwall, J. (1975). Reinforcement schedules and extrapolations to humans from animals in behavioral pharmacology. In: Weiss, B., Laties, V.G. (eds) Behavioral Pharmacology. FASEB Monographs, vol 4. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-2634-2_20
Download citation
DOI: https://doi.org/10.1007/978-1-4684-2634-2_20
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-2636-6
Online ISBN: 978-1-4684-2634-2
eBook Packages: Springer Book Archive